Sign inJoin waitlistJoin the waitlist

Corrine Zarwan

Physician · Lahey Clinic

Credentials: · · ·

History

Lahey Clinic
Present

Medical Oncology
2003–2005
Beth Israel Deaconess Medical Center
2000–2003
Univ of Florida Coll of Med
1996–2000
University of Florida
1992–1996

Research

Open-label Clinical Trial of Niraparib Combined With Pembrolizumab for Treatment of Advanced or Metastatic Triple-Negative Breast Cancer
JAMA Oncology · 2019 · 378 citations
Cediranib, an oral inhibitor of vascular endothelial growth factor receptor kinases, is an active drug in recurrent epithelial ovarian, fallopian tube, and peritoneal cancer
Journal of Clinical Oncology · 2009 · 238 citations
Avelumab in patients with previously treated metastatic adrenocortical carcinoma: phase 1b results from the JAVELIN solid tumor trial
Journal for ImmunoTherapy of Cancer · 2018 · 144 citations

Banu Arun
5 papers
David Avigan
5 papers
Dawn Hershman
5 papers
Katherine Crew
5 papers
DK
Donald Kufe
4 papers
Jacalyn Rosenblatt
4 papers
Susan Pories
4 papers
Alison Conlin
3 papers
Ana Leon
3 papers
Andrea Kaster
3 papers
Cathy Graham
3 papers
CD
Claudia Deyoung
3 papers

Clinical trials

Stereotactic Body Radiation Therapy (SBRT) vs Trans-Arterial Chemoembolization (TACE) as Bridge to Transplant
Principal investigator · Terminated · Phase 3
Lahey Clinic
2020–2024
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers
Site PI · Recruiting
Beth Israel Deaconess Medical Center
2026–2033
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2023–2032
ATEMPT 2.0: Adjuvant T-DM1 vs TH
Site PI · Recruiting · Phase 2
Dana-Farber Cancer Institute
2021–2029